We are live on
!
Find out more
HP
Hikari Power Portfolio holdings
AUM
$855M
1-Year Est. Return
14.24%
This Fund
S&P 500
This Quarter
Est. Return
+12.04%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$1.16B
AUM Growth
+$114M
(+11%)
Cap. Flow
-$2.42M
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
74.62%
Holding
64
New
–
Increased
1
Reduced
2
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$79.3K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$1.87M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$380K |
| 3 |
Elevance Health
ELV
|
+$240K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 51.58% |
| 2 | Healthcare | 17.23% |
| 3 | Materials | 8.1% |
| 4 | Energy | 7.63% |
| 5 | Technology | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class A
BRK.A
$1.11T
| $497M | 42.7% |
783
| – | – |
|
2
Linde
LIN
$226B
| $72.9M | 6.27% |
157,080
| – | – |
|
3
Johnson & Johnson
JNJ
$626B
| $53.7M | 4.62% |
339,440
| – | – |
|
4
Danaher
DHR
$146B
| $46.2M | 3.97% |
185,170
| – | – |
|
5
Visa
V
$677B
| $42.9M | 3.69% |
153,680
| – | – |
|
6
Roper Technologies
ROP
$39.5B
| $41.7M | 3.59% |
74,390
| – | – |
|
7
ExxonMobil
XOM
$657B
| $34.8M | 2.99% |
299,290
| – | – |
|
8
Phillips 66
PSX
$89.5B
| $31.1M | 2.67% |
190,330
| – | – |
|
9
Shell
SHEL
$250B
| $22.9M | 1.97% |
341,900
| – | – |
|
10
Alphabet (Google) Class C
GOOG
$4.19T
| $21.3M | 1.83% |
140,000
| – | – |
|
11
Moody's
MCO
$82.5B
| $20.7M | 1.78% |
52,700
| – | – |
|
12
Intuitive Surgical
ISRG
$142B
| $19.7M | 1.69% |
49,410
| – | – |
|
13
Altria Group
MO
$109B
| $19.1M | 1.64% |
438,340
| – | – |
|
|
NVO
14
Novo Nordisk
NVO
$207B
| $16.7M | 1.44% |
130,300
-15,750
| -11% | -$1.87M |
|
15
Waters Corp
WAT
$40.7B
| $16.4M | 1.41% |
47,630
| – | – |
|
|
BNY
16
Bank of New York Mellon
BNY
$109B
| $14.1M | 1.21% |
244,800
| – | – |
|
17
Nutrien
NTR
$32.1B
| $11.9M | 1.03% |
219,710
| – | – |
|
18
Wabtec
WAB
$50.3B
| $9.98M | 0.86% |
68,523
| – | – |
|
19
AbbVie
ABBV
$442B
| $9.75M | 0.84% |
53,543
| – | – |
|
20
Vanguard S&P 500 ETF
VOO
$1.03T
| $9.23M | 0.79% |
19,200
| – | – |
|
21
Amgen
AMGN
$224B
| $8.81M | 0.76% |
30,990
| – | – |
|
22
Cigna
CI
$72.4B
| $8.68M | 0.75% |
23,899
| – | – |
|
23
BHP
BHP
$229B
| $8.5M | 0.73% |
147,400
| – | – |
|
24
Wells Fargo
WFC
$264B
| $7.56M | 0.65% |
130,460
| – | – |
|
25
Medtronic
MDT
$116B
| $6.89M | 0.59% |
79,060
| – | – |
|
Similar funds
QIM
NOCM
OAM
EPIMS
BCM
PCM
BOTOTLSJU
TSS
Hikari Power's Q1 2024 Portfolio in Review
As of Q1 2024, Hikari Power held 64 positions worth $1.16B, up 11% from $1.05B the previous quarter. Its ten largest holdings account for 75% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 1.6%. Hikari Power opened no new positions and exited 1, leaving the 64-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 52% of assets, up from 50% a quarter earlier, followed by Healthcare and Materials.
- Hikari Power added most to 3M in Q1 2024, an estimated $79.3K increase.
- Hikari Power's biggest Q1 2024 reduction was Novo Nordisk, cutting an estimated $1.87M.
- Hikari Power fully exited Elevance Health in Q1 2024, selling an estimated $240K.
- Hikari Power's ten largest holdings make up 75% of its $1.16B portfolio in Q1 2024.
- Hikari Power opened 0 new positions and closed 1 in Q1 2024.
- Hikari Power's portfolio value rose 11% quarter-over-quarter to $1.16B.
Based on Hikari Power's 13F filing for Q1 2024, filed 8 May 2024.